Morey A. Blinder

3.9k total citations
56 papers, 2.3k citations indexed

About

Morey A. Blinder is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Morey A. Blinder has authored 56 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Genetics, 33 papers in Hematology and 8 papers in Molecular Biology. Recurrent topics in Morey A. Blinder's work include Hemoglobinopathies and Related Disorders (25 papers), Iron Metabolism and Disorders (15 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). Morey A. Blinder is often cited by papers focused on Hemoglobinopathies and Related Disorders (25 papers), Iron Metabolism and Disorders (15 papers) and Blood Coagulation and Thrombosis Mechanisms (7 papers). Morey A. Blinder collaborates with scholars based in United States, Canada and Netherlands. Morey A. Blinder's co-authors include Alan E. Mast, Douglas M. Tollefsen, Mitchell G. Scott, Ann M. Gronowski, Dennis J. Dietzen, Joshua J. Field, Sherri Flax, Qing Lü, Jayne Marasa and Francis Vekeman and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Morey A. Blinder

56 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Morey A. Blinder United States 26 1.5k 1.0k 270 263 199 56 2.3k
Fitzroy W. Dawkins United States 25 1.3k 0.8× 977 0.9× 125 0.5× 327 1.2× 49 0.2× 48 2.5k
Richard D. Press United States 31 1.9k 1.3× 1.4k 1.4× 151 0.6× 550 2.1× 23 0.1× 105 2.8k
Laszlo Bajzar Canada 27 2.5k 1.7× 516 0.5× 649 2.4× 563 2.1× 63 0.3× 38 3.5k
Jacques‐Olivier Bay France 25 891 0.6× 386 0.4× 244 0.9× 702 2.7× 67 0.3× 151 2.4k
Prasad Mathew United States 28 1.3k 0.9× 328 0.3× 137 0.5× 587 2.2× 42 0.2× 90 3.0k
Gaetano Bergamaschi Italy 30 1.9k 1.3× 1.4k 1.4× 60 0.2× 962 3.7× 61 0.3× 108 3.3k
G Souillet France 29 1.1k 0.7× 560 0.5× 85 0.3× 312 1.2× 91 0.5× 105 2.8k
G Isacchi Italy 20 685 0.5× 244 0.2× 160 0.6× 440 1.7× 77 0.4× 75 1.6k
Daniela Cilloni Italy 33 2.7k 1.8× 1.6k 1.6× 353 1.3× 1.6k 6.0× 69 0.3× 181 4.4k
Roberto Passetto Falcão Brazil 26 584 0.4× 357 0.3× 329 1.2× 958 3.6× 63 0.3× 132 2.2k

Countries citing papers authored by Morey A. Blinder

Since Specialization
Citations

This map shows the geographic impact of Morey A. Blinder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morey A. Blinder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morey A. Blinder more than expected).

Fields of papers citing papers by Morey A. Blinder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morey A. Blinder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morey A. Blinder. The network helps show where Morey A. Blinder may publish in the future.

Co-authorship network of co-authors of Morey A. Blinder

This figure shows the co-authorship network connecting the top 25 collaborators of Morey A. Blinder. A scholar is included among the top collaborators of Morey A. Blinder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morey A. Blinder. Morey A. Blinder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blinder, Morey A., et al.. (2015). Age-Related Emergency Department Reliance in Patients with Sickle Cell Disease. Journal of Emergency Medicine. 49(4). 513–522.e1. 59 indexed citations
2.
Blinder, Morey A., et al.. (2014). High Cost Patients And Cost Patterns From Pediatric To Adult Care In A Medicaid Population With Sickle Cell Disease. Value in Health. 17(3). A137–A137. 1 indexed citations
3.
Blinder, Morey A., et al.. (2014). Exertional Sickling: Questions and Controversy. Hematology Reports. 6(4). 5502–5502. 11 indexed citations
4.
Blinder, Morey A., et al.. (2013). Age‐related treatment patterns in sickle cell disease patients and the associated sickle cell complications and healthcare costs. Pediatric Blood & Cancer. 60(5). 828–835. 99 indexed citations
5.
Rodgers, George M., Pamela S. Becker, Morey A. Blinder, et al.. (2012). Cancer- and Chemotherapy-Induced Anemia. Journal of the National Comprehensive Cancer Network. 10(5). 628–653. 171 indexed citations
6.
Cohen, Robyn T., et al.. (2011). Recurrent, severe wheezing is associated with morbidity and mortality in adults with sickle cell disease. American Journal of Hematology. 86(9). 756–761. 45 indexed citations
7.
Field, Joshua J., et al.. (2009). Sustained response with rituximab in patients with thrombotic thrombocytopenic purpura: A report of 13 cases and review of the literature. American Journal of Hematology. 84(7). 418–421. 43 indexed citations
8.
Field, Joshua J., James G. Krings, Yan Yan, et al.. (2008). Urinary cysteinyl leukotriene E4 is associated with increased risk for pain and acute chest syndrome in adults with sickle cell disease. American Journal of Hematology. 84(3). 158–160. 19 indexed citations
9.
Goers, Trudie A., Julie A. Panepinto, Michael R. DeBaun, et al.. (2007). Laparoscopic versus open abdominal surgery in children with sickle cell disease is associated with a shorter hospital stay. Pediatric Blood & Cancer. 50(3). 603–606. 26 indexed citations
10.
Lau, Michelle, Morey A. Blinder, Kathryn Williams, & Leesa M. Galatz. (2007). Shoulder arthroplasty in sickle cell patients with humeral head avascular necrosis. Journal of Shoulder and Elbow Surgery. 16(2). 129–134. 19 indexed citations
11.
Mast, Alan E., Morey A. Blinder, & Dennis J. Dietzen. (2007). Reticulocyte hemoglobin content. American Journal of Hematology. 83(4). 307–310. 115 indexed citations
12.
Field, Joshua J., Leonard Giannone, Monica Bessler, & Morey A. Blinder. (2006). Immunosuppressive Therapy for Acute Porphyria: Safety and Efficacy in a Patient with Bone Marrow Failure. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(11). 1662–1666. 1 indexed citations
13.
Field, Joshua J., Timothy S. Fenske, & Morey A. Blinder. (2006). Rituximab for the treatment of patients with very high‐titre acquired factor VIII inhibitors refractory to conventional chemotherapy. Haemophilia. 13(1). 46–50. 34 indexed citations
14.
Tabrizi, Arash Rafii, Sean McGrath, Morey A. Blinder, et al.. (2001). Extreme warfarin sensitivity in siblings associated with multiple cytochrome P450 polymorphisms. American Journal of Hematology. 67(2). 144–146. 12 indexed citations
15.
Bodó, Imre, Marion G. Peters, Jerald P. Radich, et al.. (1999). Donor-Derived Acute Promyelocytic Leukemia in a Liver-Transplant Recipient. New England Journal of Medicine. 341(11). 807–813. 44 indexed citations
16.
Colwell, Niall S., Morey A. Blinder, Manuel Tsiang, et al.. (1998). Allosteric Effects of a Monoclonal Antibody against Thrombin Exosite II. Biochemistry. 37(43). 15057–15065. 28 indexed citations
17.
Colwell, Niall S., Douglas M. Tollefsen, & Morey A. Blinder. (1997). Identification of a Monoclonal Thrombin Inhibitor Associated with Multiple Myeloma and a Severe Bleeding Disorder. British Journal of Haematology. 97(1). 219–226. 33 indexed citations
18.
Fu, Yang‐Xin, et al.. (1996). Multimodality therapy of an acquired factor V inhibitor. American Journal of Hematology. 51(4). 315–318. 34 indexed citations
19.
Lutz, Steffi, et al.. (1991). Complete nucleotide sequence of the gene for human heparin cofactor II and mapping to chromosomal band 22q11. Biochemistry. 30(5). 1350–1357. 26 indexed citations
20.
Blinder, Morey A., Jayne Marasa, Craig H. Reynolds, Larry L. Deaven, & Douglas M. Tollefsen. (1988). Heparin cofactor II: cDNA sequence, chromosome localization, restriction fragment length polymorphism, and expression in Escherichia coli. Biochemistry. 27(2). 752–759. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fitzroy W. Dawkins Breakdown of academic impact, for papers by Richard D. Press Breakdown of academic impact, for papers by Laszlo Bajzar Breakdown of academic impact, for papers by Jacques‐Olivier Bay Breakdown of academic impact, for papers by Prasad Mathew Breakdown of academic impact, for papers by Gaetano Bergamaschi Breakdown of academic impact, for papers by G Souillet Breakdown of academic impact, for papers by G Isacchi Breakdown of academic impact, for papers by Daniela Cilloni Breakdown of academic impact, for papers by Roberto Passetto Falcão
Rankless by CCL
2026